Equities research analysts at StockNews.com started coverage on shares of Transcontinental Realty Investors (NYSE:TCI – Get Free Report) in a report released on Tuesday. The firm set a “sell” rating on the real estate investment trust’s stock.
Transcontinental Realty Investors Stock Performance
Shares of TCI opened at $27.80 on Tuesday. The stock has a market cap of $240.19 million, a PE ratio of 40.29 and a beta of 0.60. Transcontinental Realty Investors has a fifty-two week low of $26.79 and a fifty-two week high of $43.40. The firm’s 50-day simple moving average is $28.38 and its two-hundred day simple moving average is $28.89.
Institutional Investors Weigh In On Transcontinental Realty Investors
An institutional investor recently bought a new position in Transcontinental Realty Investors stock. Renaissance Technologies LLC purchased a new stake in shares of Transcontinental Realty Investors, Inc. (NYSE:TCI – Free Report) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 7,900 shares of the real estate investment trust’s stock, valued at approximately $219,000. Renaissance Technologies LLC owned about 0.09% of Transcontinental Realty Investors as of its most recent SEC filing.
Transcontinental Realty Investors Company Profile
Transcontinental Realty Investors, Inc, a Dallas-based real estate investment company, holds a diverse portfolio of equity real estate located across the U.S., including office buildings, apartments, shopping centers, and developed and undeveloped land. The Company invests in real estate through direct ownership, leases and partnerships and invests in mortgage loans on real estate.
See Also
- Five stocks we like better than Transcontinental Realty Investors
- Energy and Oil Stocks Explained
- Intel: Is Now the Time to Be Brave?
- Dividend Payout Ratio Calculator
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Insider Trades May Not Tell You What You Think
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Transcontinental Realty Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcontinental Realty Investors and related companies with MarketBeat.com's FREE daily email newsletter.